March 4, 2019 — Since the turn of the century, the use of biomarkers in drug discovery and development has exploded at an unprecedented rate. Recent scientific and technologic breakthroughs allow biomarkers to be leveraged to address many questions about biological activity, safety, and clinical efficacy throughout the drug discovery and development process—at a fraction of the cost and with turnaround times unimaginable less than a decade ago. Chad Clark et al., of Precision for Medicine, identify how these advances are driving a paradigm shift in drug discovery and development.

Read more